The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety results of TQB2930, a HER2-targeted bispecific antibody combined with chemotherapy in patients with HER2-positive breast cancer (BC) previously treated with =2 line treatments: Results from a phase 1b/2 study.
 
Qingyuan Zhang
No Relationships to Disclose
 
Wenhui Zhao
No Relationships to Disclose
 
Jingxuan Wang
No Relationships to Disclose
 
Tao Wu
No Relationships to Disclose
 
Weimin Xie
No Relationships to Disclose
 
Hongxue Wang
No Relationships to Disclose
 
Xiaohua Zeng
No Relationships to Disclose
 
Mingxi Jing
No Relationships to Disclose
 
Peijian Peng
No Relationships to Disclose
 
Peng Yuan
No Relationships to Disclose
 
Jin Yang
No Relationships to Disclose
 
Huihui Li
No Relationships to Disclose
 
Jing Sun
No Relationships to Disclose
 
Anqin Zhang
No Relationships to Disclose
 
Jun Zhang
No Relationships to Disclose
 
Huiqun Fu
No Relationships to Disclose
 
Zhihong Wang
No Relationships to Disclose
 
Xinghua Han
No Relationships to Disclose
 
Haifeng Cai
No Relationships to Disclose
 
Hua Yang
No Relationships to Disclose